Ledipasvir & sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg The NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes. Sofosbuvir USP/Ph.Eur. 400 mg The NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Binder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption) *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).
Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg Global Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Solubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).
Sofosbuvir 400 mg tablet + Ledipasvir 90 mg Tablet
FreeA tablet containing Sofosbuvir 400 mg + Ledipasvir 90 mg is a fixed-dose combination antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection, specifically targeting genotypes 1, 4, 5, and 6.
Sofosbuvir Tablet
FreeA Sofosbuvir 400 mg tablet is a direct-acting antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection. It belongs to the nucleotide polymerase inhibitor class and works by blocking the NS5B protein, which the virus needs to replicate.
Showing all 4 results
